Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 253

1.
2.

Depressive disorders and suicide attempts in injecting drug users with and without HIV infection.

Malbergier A, de Andrade AG.

AIDS Care. 2001 Feb;13(1):141-50.

PMID:
11177471
3.

Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia.

Rhodes T, Platt L, Judd A, Mikhailova LA, Sarang A, Wallis N, Alpatova T, Hickman M, Parry JV.

Int J STD AIDS. 2005 Nov;16(11):749-54.

PMID:
16303071
4.

HIV and hepatitis C virus risk in new and longer-term injecting drug users in Oslo, Norway.

Miller M, Mella I, Moi H, Eskild A.

J Acquir Immune Defic Syndr. 2003 Jul 1;33(3):373-9.

PMID:
12843749
5.

[Health related quality of life among HIV-HCV co-infected patients].

Préau M, Protopopescu C, Spire B, Dellamonica P, Poizot-Martin I, Villes V, Carrieri MP; Groupe d'etude MANIF-2000.

Rev Epidemiol Sante Publique. 2006 Jul;54 Spec No 1:1S33-1S43. French.

PMID:
17073128
6.

Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.

Devi KhS, Brajachand N, Singh HL, Singh YM.

J Commun Dis. 2005 Mar;37(1):73-7.

PMID:
16637404
7.

Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among injection drug users in Georgia.

Shapatava E, Nelson KE, Tsertsvadze T, del Rio C.

Drug Alcohol Depend. 2006 Apr;82 Suppl 1:S35-8.

PMID:
16769443
8.

Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study.

Rhodes T, Platt L, Maximova S, Koshkina E, Latishevskaya N, Hickman M, Renton A, Bobrova N, McDonald T, Parry JV.

Addiction. 2006 Feb;101(2):252-66.

PMID:
16445554
9.

The impact of chronic hepatitis C virus infection on HIV disease and progression in intravenous drug users.

Haydon GH, Flegg PJ, Blair CS, Brettle RP, Burns SM, Hayes PC.

Eur J Gastroenterol Hepatol. 1998 Jun;10(6):485-9.

PMID:
9855064
10.

Hepatitis C infection among drug users in northern Thailand.

Jittiwutikarn J, Thongsawat S, Suriyanon V, Maneekarn N, Celentano D, Razak MH, Srirak N, Vongchak T, Kawichai S, Thomas D, Sripaipan T, Netski D, Ananthakrishnan A, Nelson KE.

Am J Trop Med Hyg. 2006 Jun;74(6):1111-6.

PMID:
16760529
11.

Association of HCV and HBV markers in Spanish HIV-seropositive patients in relation to risk practices.

Rodríguez-Méndez ML, González-Quintela A, Aguilera A, Carballo E, Barrio E.

Hepatogastroenterology. 2003 Nov-Dec;50(54):2093-7.

PMID:
14696471
12.

Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.

Vicknasingam B, Narayanan S, Navaratnam V.

Drug Alcohol Rev. 2009 Jul;28(4):447-54. doi: 10.1111/j.1465-3362.2009.00087.x.

PMID:
19594801
13.

Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan.

Liu JY, Lin HH, Liu YC, Lee SS, Chen YL, Hung CC, Ko WC, Huang CK, Lai CH, Chen YS, Shih YL, Chung HC, Liang SH, Lin JN.

Clin Infect Dis. 2008 Jun 1;46(11):1761-8. doi: 10.1086/587992.

PMID:
18433337
14.

Coinfection with HIV and hepatitis C virus among injection drug users in southern China.

Garten RJ, Zhang J, Lai S, Liu W, Chen J, Yu XF.

Clin Infect Dis. 2005 Jul 1;41 Suppl 1:S18-24.

PMID:
16265609
15.

Anxiety and depression among HIV-infected heterosexuals--a report from India.

Chandra PS, Ravi V, Desai A, Subbakrishna DK.

J Psychosom Res. 1998 Nov;45(5):401-9.

PMID:
9835233
16.

Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.

Babudieri S, Longo B, Sarmati L, Starnini G, Dori L, Suligoi B, Carbonara S, Monarca R, Quercia G, Florenzano G, Novati S, Sardu A, Iovinella V, Casti A, Romano A, Uccella I, Maida I, Brunetti B, Mura MS, Andreoni M, Rezza G.

J Med Virol. 2005 Jul;76(3):311-7.

PMID:
15902712
17.

Influence of depression and HIV serostatus on the neuropsychological performance of injecting drug users.

Waldrop-Valverde D, Ownby RL, Kumar M.

Psychiatry Clin Neurosci. 2005 Aug;59(4):372-8.

18.

Hepatitis C virus infection: prevalence, predictor variables and prevention opportunities among drug users in Italy.

Quaglio GL, Lugoboni F, Pajusco B, Sarti M, Talamini G, Mezzelani P, Des Jarlais DC; GICS.

J Viral Hepat. 2003 Sep;10(5):394-400.

PMID:
12969192
19.

Risk Factors and predictors of human immunodeficiency virus infection among injection drug users.

Backmund M, Meyer K, Henkel C, Reimer J, Wächtler M, Schütz CG.

Eur Addict Res. 2005;11(3):138-44.

PMID:
15990431
20.

The neuropsychological and neurological impact of hepatitis C virus co-infection in HIV-infected subjects.

Clifford DB, Evans SR, Yang Y, Gulick RM.

AIDS. 2005 Oct;19 Suppl 3:S64-71.

PMID:
16251830

Supplemental Content

Support Center